Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain

Second-generation antipsychotics (SGAs) are the cornerstone of treatment for schizophrenia because of their high clinical efficacy. However, SGA treatment is associated with severe metabolic alterations and body weight gain, which can increase the risk of type 2 diabetes and cardiovascular disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grajales, Diana, Ferreira, Vitor, Valverde, Ángela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912706/
https://www.ncbi.nlm.nih.gov/pubmed/31671770
http://dx.doi.org/10.3390/cells8111336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912706/
https://www.ncbi.nlm.nih.gov/pubmed/31671770
http://dx.doi.org/10.3390/cells8111336

Ejemplares similares